Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lehwald

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Pediatric Neurology|July 21, 2020
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US ClinicsEmily de Los Reyes, Lenora Lehwald, Erika F Augustine, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
Pediatric Neurology|March 25, 2017
Management Strategies for CLN2 DiseaseRuth E Williams, Heather R Adams, Martin Blohm, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 22, 2019
ALPPS in neuroendocrine liver metastases not amenable for conventional resection - lessons learned from an interim analysis of the International ALPPS RegistryMichael Linecker, Patryk Kambakamba, Dimitri A Raptis, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 28, 2020
Variation in complications and mortality following ALPPS at early-adopting centersKerollos N Wanis, Michael Linecker, Arin L Madenci, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 4, 2020
Hepatopancreatoduodenectomy -a controversial treatment for bile duct and gallbladder cancer from a European perspectiveMelroy A D'Souza, Valentinus T Valdimarsson, Tommaso Campagnaro, et al.
BJS Open|August 24, 2021
Liver resection and ablation for squamous cell carcinoma liver metastasesJ Engstrand, L F Abreu de Carvalho, D Aghayan, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Pediatric Neurology|July 21, 2020
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US ClinicsEmily de Los Reyes, Lenora Lehwald, Erika F Augustine, et al.
SAGE Open Medicine|November 1, 2024
Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndromeDragana Protic, Elizabeth Breeze, Guadalupe Mendoza, et al.
Pediatric Neurology|March 25, 2017
Management Strategies for CLN2 DiseaseRuth E Williams, Heather R Adams, Martin Blohm, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 22, 2019
ALPPS in neuroendocrine liver metastases not amenable for conventional resection - lessons learned from an interim analysis of the International ALPPS RegistryMichael Linecker, Patryk Kambakamba, Dimitri A Raptis, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 28, 2020
Variation in complications and mortality following ALPPS at early-adopting centersKerollos N Wanis, Michael Linecker, Arin L Madenci, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 4, 2020
Hepatopancreatoduodenectomy -a controversial treatment for bile duct and gallbladder cancer from a European perspectiveMelroy A D'Souza, Valentinus T Valdimarsson, Tommaso Campagnaro, et al.
BJS Open|August 24, 2021
Liver resection and ablation for squamous cell carcinoma liver metastasesJ Engstrand, L F Abreu de Carvalho, D Aghayan, et al.
Pageof 8